Global Service Integration and Management (SIAM) Market is expected to reach USD 5.4 billion by 2025, witnessing 5.3% CAGR during the forecast period 2020–2025

    NEXT STORY
    Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita® (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO)
    PREV STORY
    RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK 
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AiViva Biopharma Announces Positive Data from Phase 1/2a Clinical Trial of AIV001 for Dermal Scarring and Wound Healing

    author_avatar
    NASDAQ Market News

    Sorrento Therapeutics Announces Proposed Public Offering of Common Stock and Warrants

    author_avatar
    NASDAQ Market News

    Positive clinical phase III results of vortioxetine in Japanese adults with Major Depressive Disorder

    New clinical phase III data from a study conducted in Japan demonstrate the efficacy ...

    author_avatar
    NASDAQ Market News